X-SYNERGY Trademark

Trademark Overview


On Thursday, April 6, 2017, a trademark application was filed for X-SYNERGY with the United States Patent and Trademark Office. The USPTO has given the X-SYNERGY trademark a serial number of 87402113. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Friday, February 15, 2019. This trademark is owned by Kangpu Biopharmaceuticals, Ltd.. The X-SYNERGY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues; Pharmaceutical product evaluation not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues; Pharmaceutical products development not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues; Pharmaceutical research and development not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues; Technical research in the field of pharmaceutical studies not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irrita...
x-synergy

General Information


Serial Number87402113
Word MarkX-SYNERGY
Filing DateThursday, April 6, 2017
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateFriday, February 15, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical drug development services not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues; Pharmaceutical product evaluation not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues; Pharmaceutical products development not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues; Pharmaceutical research and development not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues; Technical research in the field of pharmaceutical studies not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues; Analysis of the mode of action of chemical combinations on animals; Chemical, biochemical, biological and bacteriological research and analysis not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues; Providing a website featuring information about investigational medical devices, diagnostics and drugs; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues; Research on the subject of pharmaceuticals not in the fields of gastrointestinal diseases and disorders, digestive functions, constipation, irritable bowel syndrome, colitis, and gastrointestinal hormone analogues

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 13, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKangpu Biopharmaceuticals, Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressShanghai
CN

Trademark Events


Event DateEvent Description
Tuesday, February 19, 2019ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Friday, February 15, 2019ABANDONMENT - AFTER EX PARTE APPEAL
Friday, February 15, 2019EXPARTE APPEAL TERMINATED
Monday, January 7, 2019EXPARTE APPEAL DSMSED - FAILURE TO FILE BRIEF
Saturday, July 14, 2018NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Saturday, July 14, 2018SUBSEQUENT FINAL EMAILED
Saturday, July 14, 2018SUBSEQUENT FINAL REFUSAL WRITTEN
Wednesday, July 11, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 11, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 11, 2018ASSIGNED TO LIE
Friday, June 22, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, June 23, 2018EX PARTE APPEAL-INSTITUTED
Saturday, June 23, 2018JURISDICTION RESTORED TO EXAMINING ATTORNEY
Saturday, June 23, 2018EXPARTE APPEAL RECEIVED AT TTAB
Friday, December 22, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, December 22, 2017FINAL REFUSAL E-MAILED
Friday, December 22, 2017FINAL REFUSAL WRITTEN
Friday, December 1, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 30, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 30, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 6, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 6, 2017NON-FINAL ACTION E-MAILED
Tuesday, June 6, 2017NON-FINAL ACTION WRITTEN
Tuesday, June 6, 2017ASSIGNED TO EXAMINER
Thursday, April 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 10, 2017NEW APPLICATION ENTERED IN TRAM